VRDN-003, a Novel Half-life Extended IGF-1 Receptor Antibody for Thyroid Eye Disease (TED): Preclinical Pharmacokinetics. Annual Meeting of The American Academy of Ophthalmology November 2023.

viridian-therapeutics-AAO-2023-ePoster-003-cyno-1